title: Marked eosinophilia in an immunosuppressed patient with strongyloidiasis.
abstract: Strongyloidiasis in immunocompromised patients is typically associated with a fulminant clinical course and little eosinophilia. We describe an immunocompromised patient with strongyloidiasis in whom the infection was only minimally symptomatic in association with a dramatic increase in eosinophil count.
authors.affiliation: Department of Haematology, Charing Cross Hospital, London, UK.
authors.forename: D
authors.initials: D
authors.lastname: Savage
authors.forename: M
authors.initials: M
authors.lastname: Foadi
authors.forename: C
authors.initials: C
authors.lastname: Haworth
authors.forename: A
authors.initials: A
authors.lastname: Grant
mesh_terms: D000328:Adult; D000818:Animals; D001859:Bone Neoplasms / Q000628:therapy; D003131:Combined Modality Therapy / Q000009:adverse effects; D004802:Eosinophilia / Q000469:parasitology*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009101:Multiple Myeloma / Q000628:therapy; D017171:Strongyloides stercoralis; D013322:Strongyloidiasis / Q000150:complications* / Q000276:immunology